| Sandra Jean Mcdonald, APRN | |
|
1 Medical Center Dr, Lebanon, NH 03756-0001 | |
| (603) 650-5104 | |
| Not Available |
| Full Name | Sandra Jean Mcdonald |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 8 Years |
| Location | 1 Medical Center Dr, Lebanon, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245689868 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mary Hitchcock Memorial Hospital | Lebanon, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dartmouth-hitchcock Clinic | 4183537509 | 1139 |
News Archive
Atherotech Diagnostics Lab, a leading clinical reference laboratory specializing in cardiometabolic testing and disease management solutions, today announced the opening of its patient service center in Sarasota, Fla. A physician open house on Wednesday, November 6, 2013, from 5:00 p.m. until 8:00 p.m. at 4014 Sawyer Road in Sarasota, Fla., celebrates the opening of the center.
As of late May, COVID-19 has killed more than 325,000 people around the world. Even though the worst seems to be over for countries like China and South Korea, public health experts warn that cases and fatalities will continue to surge in many parts of the world.
Organizations that seek to provide health care, food, and other services to people held in drug detention centers in developing countries often face ethical dilemmas: Are they doing more good than harm? Are they helping detainees or legitimizing a corrupt system and ultimately building its capacity to detain and abuse more people?
Orexigen Therapeutics, Inc. announced today that it recently met with the Food and Drug Administration (FDA) regarding the New Drug Application for Contrave (naltrexone HCl/bupropion HCl) extended-release tablets for the treatment of obesity, including weight loss and maintenance of weight loss.
› Verified 4 days ago
| Entity Name | Mary Hitchcock Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023092053 PECOS PAC ID: 4486561164 Enrollment ID: O20031126000258 |
News Archive
Atherotech Diagnostics Lab, a leading clinical reference laboratory specializing in cardiometabolic testing and disease management solutions, today announced the opening of its patient service center in Sarasota, Fla. A physician open house on Wednesday, November 6, 2013, from 5:00 p.m. until 8:00 p.m. at 4014 Sawyer Road in Sarasota, Fla., celebrates the opening of the center.
As of late May, COVID-19 has killed more than 325,000 people around the world. Even though the worst seems to be over for countries like China and South Korea, public health experts warn that cases and fatalities will continue to surge in many parts of the world.
Organizations that seek to provide health care, food, and other services to people held in drug detention centers in developing countries often face ethical dilemmas: Are they doing more good than harm? Are they helping detainees or legitimizing a corrupt system and ultimately building its capacity to detain and abuse more people?
Orexigen Therapeutics, Inc. announced today that it recently met with the Food and Drug Administration (FDA) regarding the New Drug Application for Contrave (naltrexone HCl/bupropion HCl) extended-release tablets for the treatment of obesity, including weight loss and maintenance of weight loss.
› Verified 4 days ago
| Entity Name | Dartmouth-hitchcock Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548210198 PECOS PAC ID: 4183537509 Enrollment ID: O20040809000442 |
News Archive
Atherotech Diagnostics Lab, a leading clinical reference laboratory specializing in cardiometabolic testing and disease management solutions, today announced the opening of its patient service center in Sarasota, Fla. A physician open house on Wednesday, November 6, 2013, from 5:00 p.m. until 8:00 p.m. at 4014 Sawyer Road in Sarasota, Fla., celebrates the opening of the center.
As of late May, COVID-19 has killed more than 325,000 people around the world. Even though the worst seems to be over for countries like China and South Korea, public health experts warn that cases and fatalities will continue to surge in many parts of the world.
Organizations that seek to provide health care, food, and other services to people held in drug detention centers in developing countries often face ethical dilemmas: Are they doing more good than harm? Are they helping detainees or legitimizing a corrupt system and ultimately building its capacity to detain and abuse more people?
Orexigen Therapeutics, Inc. announced today that it recently met with the Food and Drug Administration (FDA) regarding the New Drug Application for Contrave (naltrexone HCl/bupropion HCl) extended-release tablets for the treatment of obesity, including weight loss and maintenance of weight loss.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sandra Jean Mcdonald, APRN 1 Medical Center Dr, Lebanon, NH 03756-0001 Ph: () - | Sandra Jean Mcdonald, APRN 1 Medical Center Dr, Lebanon, NH 03756-0001 Ph: (603) 650-5104 |
News Archive
Atherotech Diagnostics Lab, a leading clinical reference laboratory specializing in cardiometabolic testing and disease management solutions, today announced the opening of its patient service center in Sarasota, Fla. A physician open house on Wednesday, November 6, 2013, from 5:00 p.m. until 8:00 p.m. at 4014 Sawyer Road in Sarasota, Fla., celebrates the opening of the center.
As of late May, COVID-19 has killed more than 325,000 people around the world. Even though the worst seems to be over for countries like China and South Korea, public health experts warn that cases and fatalities will continue to surge in many parts of the world.
Organizations that seek to provide health care, food, and other services to people held in drug detention centers in developing countries often face ethical dilemmas: Are they doing more good than harm? Are they helping detainees or legitimizing a corrupt system and ultimately building its capacity to detain and abuse more people?
Orexigen Therapeutics, Inc. announced today that it recently met with the Food and Drug Administration (FDA) regarding the New Drug Application for Contrave (naltrexone HCl/bupropion HCl) extended-release tablets for the treatment of obesity, including weight loss and maintenance of weight loss.
› Verified 4 days ago
Mrs. Janice M Brennan, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Dhmc Department Of Occupation Medicine, Lebanon, NH 03756 Phone: 603-560-5000 Fax: 603-650-0787 | |
Meredith Anne Stringer, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5000 | |
Carol Williams-suich, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5 Alice Peck Day Dr, Lebanon, NH 03766 Phone: 603-448-3122 Fax: 603-448-7491 | |
Cassandra M Godzik, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: One Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-7232 | |
Deann Opal Mcnamara, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5922 | |
Emily L Swann, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Dr, Lebanon, NH 03756 Phone: 603-650-6224 | |
Molly P Keady, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-8622 |